Questionnaire for patient input for the medical device Evoke Spinal Cord Stimulation (SCS) System®

We kindly ask patient organisations to complete this online questionnaire until December 14, EOB.

Introduction

EUnetHTA 21 recognises that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. Furthermore, EUnetHTA 21 believes that patient organisations can help in understanding the unique perspectives of patients by collecting and presenting patients’ views and experiences via engagement with a wide range of patients. Experience may relate to the entire life cycle of the patient, including phases of the disease/conditions and/or outcomes the patient is no longer experiencing now and/or treatments patients have received in the past. These organisations can describe the advantages and disadvantages of health technologies on the basis of patients’ experiences and what patients value for a new technology.

Organisations completing this questionnaire
Organisations contributing via this patient input template should ideally be situated in EU/EEA countries. Please note that EUnetHTA only accepts one consolidated template per organisation. Input from stakeholders obtained during the JCA scoping process may also be shared with national Health Technology Assessment bodies.

What type of information is most helpful?

Each question has a series of prompts. Please address any of the prompts that you feel are important and describe any other relevant issues that are not captured in the list of prompts. You are not expected to consider or go into depth with every single prompt.

Describe experiences at different stages of the condition/disease (and if applicable differences in the severity of the disease), with a particular focus on symptoms in terms of their impact and how well they are currently managed with existing treatments.

Where possible, please provide clear facts, information and summaries of experiences that give a concise, accurate and balanced overview of a range of patients’ perspectives.

Where possible, for any of the sections in the template for which there are groups that should have special consideration, please indicate the specific needs/issues of that group (e.g., children, women/men, ethnic groups, those living in a particular location, those with other disabilities, disease subtypes).

State the source(s) of your information (e.g., web survey, helpline analysis, social networking, focus groups, patients’ records, one-to-one conversations with those who have experience with a technology, patient stories, research studies, etc.) and provide clear references where they are available.

Help in completing the template

If you require help in understanding HTA-related terms, please refer to the HTA glossary link, the EUnetHTA JCA frequently asked questions link or the Joint Scientific Consultation (JSC) page link

The template compiles possible aspects/options to consider in your response; all of the points listed are optional and do not have to be asked or answered.

If you have any further questions when completing this form, please contact JCA_Secretariat@zinl.nl.

Information about EUnetHTA´s privacy policy can be found here: link